What is NDC 68462-583?

68462-583 is the product NDC for Aprepitant, Aprepitant 40 mg/1 capsule, listed with the FDA by Glenmark Pharmaceuticals Inc., USA. It has 3 package NDCs, shown above in 10- and 11-digit form.

Glenmark Pharmaceuticals Inc., USA, NDC labeler code 68462. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Aprepitant?

19 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Aprepitant NDC 68462-583 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)68462-583Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68462-0583Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
68462-583-11	6846205831168462058311	1 BLISTER PACK in 1 CARTON (68462-583-11) / 10 CAPSULE in 1 BLISTER PACKMarketed from Oct 12, 2017
68462-583-40	6846205834068462058340	1 BLISTER PACK in 1 CARTON (68462-583-40) / 1 CAPSULE in 1 BLISTER PACKMarketed from Oct 12, 2017
68462-583-85	6846205838568462058385	5 BLISTER PACK in 1 CARTON (68462-583-85) / 1 CAPSULE in 1 BLISTER PACKMarketed from Oct 12, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Aprepitant
Generic name (nonproprietary): aprepitant
Active ingredients: Aprepitant — 40 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Glenmark Pharmaceuticals Inc., USANDC labeler code 68462
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 207777
Marketing start: Oct 12, 2017
Listing expires: Dec 31, 2027
Other FDA classes: Cytochrome P450 2C9 Inducers (Mechanism)Cytochrome P450 3A4 Inducers (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)Neurokinin 1 Antagonists (Mechanism)
Identifiers: Product ID 68462-583_39fda225-0fa7-41d3-85b1-6ea966847331SPL ID 39fda225-0fa7-41d3-85b1-6ea966847331
Pharmacologic class: Substance P/Neurokinin-1 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468462058311 followed by a unit qualifier and the quantity

Package 68462-0583-11. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 68462-583

What is NDC 68462-583?: 68462-583 is the product NDC for Aprepitant, Aprepitant 40 mg/1 capsule, listed with the FDA by Glenmark Pharmaceuticals Inc., USA. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Aprepitant.
What is the active ingredient?: Aprepitant.
Who is the labeler?: Glenmark Pharmaceuticals Inc., USA, NDC labeler code 68462. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Aprepitant?: 19 other product NDCs are listed under this name. See all Aprepitant NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Aprepitant NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Aprepitant	Aprepitant 125 mg/1	CapsuleOral	BluePoint Laboratories	68001-668	68001-0668-19
Aprepitant	—	Kit	BluePoint Laboratories	68001-669	68001-0669-15
Aprepitant	Aprepitant 40 mg/1	CapsuleOral	BluePoint Laboratories	68001-666	68001-0666-0168001-0666-17
Aprepitant	Aprepitant 80 mg/1	CapsuleOral	BluePoint Laboratories	68001-667	68001-0667-0168001-0667-19
Aprepitant	Aprepitant 40 mg/1	CapsuleOral	Torrent Pharmaceuticals Limited	13668-591	13668-0591-8113668-0591-82
Aprepitant	Aprepitant 80 mg/1	CapsuleOral	Torrent Pharmaceuticals Limited	13668-592	13668-0592-8413668-0592-86
Aprepitant	Aprepitant 125 mg/1	CapsuleOral	Torrent Pharmaceuticals Limited	13668-593	13668-0593-86
Aprepitant	—	Kit	Torrent Pharmaceuticals Limited	13668-594	13668-0594-87
Aprepitant	Aprepitant 40 mg/1	CapsuleOral	Golden State Medical Supply, Inc.	51407-701	51407-0701-0151407-0701-05
Aprepitant	Aprepitant 80 mg/1	CapsuleOral	Golden State Medical Supply, Inc.	51407-702	51407-0702-0251407-0702-06

All 20 Aprepitant NDCs

Other NDCs under ANDA 207777

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 207777
Product	Strength	Form · route	Labeler	Product NDC
Aprepitant	Aprepitant 40 mg/1	CapsuleOral	BluePoint Laboratories	68001-666
Aprepitant	Aprepitant 80 mg/1	CapsuleOral	BluePoint Laboratories	68001-667
Aprepitant	Aprepitant 125 mg/1	CapsuleOral	BluePoint Laboratories	68001-668
Aprepitant	—	Kit	BluePoint Laboratories	68001-669
Aprepitant	—	Kit	Glenmark Pharmaceuticals Inc., USA	68462-112
Aprepitant	Aprepitant 80 mg/1	CapsuleOral	Glenmark Pharmaceuticals Inc., USA	68462-584
Aprepitant	Aprepitant 125 mg/1	CapsuleOral	Glenmark Pharmaceuticals Inc., USA	68462-585